Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

US Patent 7265122 · Granted Sep 4, 2007

Estimated economic value: $2,420,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SGLT2/DPP4 inhibitor and application thereof2025
Spiro compound serving as ERK inhibitor, and application thereof2025
SGLTS/DPP4 inhibitor and application thereof2025
BRD4 inhibitor compound in solid form and preparation method therefor and use th2025
Glucoside derivative that acts as SGLT1 inhibitor and application thereof2025
Use of histone modifiers to reprogram effector T cells2024
Cyclic dinucleotide analogue, pharmaceutical composition thereof, and applicatio2024
Macrocyclic derivatives acting as XIa factor inhibitor2024
Use of Chaetomium globosum strain in controlling fusarium crown rot of wheat2024
Diarylthiohydantoin compound as androgen receptor antagonist2024
Heterocyclic compound2023
Crystal form as ASK1 inhibitor and preparation method and application thereof2023